Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 27, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-080505.pdf 0001193125-23-080505.rtf View HTML
March 27, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-080560.pdf 0001193125-23-080560.rtf View HTML
March 27, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-080563.pdf 0001193125-23-080563.rtf View HTML
March 31, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-088046.pdf 0001193125-23-088046.rtf View HTML
April 11, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-097795.pdf 0001193125-23-097795.rtf View HTML
April 14, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-101547.pdf 0001193125-23-101547.rtf View HTML
April 14, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-102245.pdf 0001193125-23-102245.rtf View HTML
April 21, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-110580.pdf 0001193125-23-110580.rtf View HTML
April 25, 2024	DEFA14A	Additional proxy soliciting materials - definitive	0001517022-24-000046.pdf 0001517022-24-000046.rtf View HTML
March 17, 2023	DEFR14A	DEFR14A	0001193125-23-073252.pdf 0001193125-23-073252.rtf 0001193125-23-073252.xls View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax